Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity
Keywords:
Cyclosporine A
Lipid nanoparticles
Oral administration
Stability
Immunosuppressive activity
Jurkat cells
Publisher:
Dove Medical Press
Citation:
Guada M, Sebastián V, Irusta S, Feijoó E, Dios-Viéitez MC, Blanco-Prieto MJ. Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity. 2015;2015(10):6541-6553.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.